<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Retrospective analysis of <italic>Streptococcus agalactiae</italic> antibiotic susceptibility isolated in 2010–2013 was performed. Penicillin was still the firstline antibiotic. Due to the high percentage of strains resistant to erythromycin and clindamycin empirical treatment with these antibiotics may not be effective. Lower resistance rate to erythromycin and clindamycin among strains isolated from infected pregnant women and newborns were observed than among strains isolated from samples from patients hospitalized in other departments (29% and 47% v. 46% and 63%). The increasing resistance rate might give a rise to a new epidemiological situation.</p>
</abstract>

Retrospective analysis of Streptococcus agalactiae antibiotic susceptibility isolated in 2010–2013 was performed. Penicillin was still the firstline antibiotic. Due to the high percentage of strains resistant to erythromycin and clindamycin empirical treatment with these antibiotics may not be effective. Lower resistance rate to erythromycin and clindamycin among strains isolated from infected pregnant women and newborns were observed than among strains isolated from samples from patients hospitalized in other departments (29% and 47% v. 46% and 63%). The increasing resistance rate might give a rise to a new epidemiological situation.

Erythromycin or Clindamycin – is it Still an Empirical Therapy against <italic>Streptococcus agalactiae</italic> in Patients Allergic to Penicillin?

Polish Journal of Microbiology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Erythromycin or Clindamycin – is it Still an Empirical Therapy against  in Patients Allergic to Penicillin?

Retrospective analysis of Streptococcus agalactiae antibiotic susceptibility isolated in 2010–2013 was performed. Penicillin was still the firstline...

Erythromycin or Clindamycin – is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin?

Publié en ligne: 28 juin 2017

Pages: 265 - 268

Reçu: 11 août 2016

Accepté: 27 janv. 2017

DOI: https://doi.org/10.5604/pjm-2017-265

Mots clés
clindamycin, erythromycin, susceptibility on antibiotics

© 2017 PIOTR LESZCZYŃSKI et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Erythromycin or Clindamycin – is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin?

Publié en ligne: 28 juin 2017

Pages: 265 - 268

Reçu: 11 août 2016

Accepté: 27 janv. 2017

DOI: https://doi.org/10.5604/pjm-2017-265

Mots clésclindamycin, erythromycin, susceptibility on antibiotics

© 2017 PIOTR LESZCZYŃSKI et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mots clés
clindamycin, erythromycin, susceptibility on antibiotics